🏥 治験ポータル
← 治験一覧に戻る

心不全と腎不全を併発している患者におけるカルペリチドの短期および長期予後への影響

基本情報

NCT ID
NCT00613964
ステータス
中止
試験のフェーズ
第4相
試験タイプ
介入
目標被験者数
200
治験依頼者名
Nara Medical University

概要

Carperitide (alpha-human atrial natriuretic peptide) improves systemic hemodynamics in patients with heart failure through a vasodilatory action, a natriuretic action, and inhibition of the renin-angiotensin-aldosterone system and has been widely-used in Japan. However, a paucity of report is available on the effects of carperitide on short and long-term prognosis in patients with both cardiac and renal failure. The purpose of this study is to evaluate the effects of carperitide therapy on short and long-term prognosis in patients with both cardiac and renal failure, in comparison with standard therapy.

対象疾患

Heart FailureRenal Failure

介入

Carperitide heart failure therapy(DRUG)
Standard heart failure therapy(DRUG)

依頼者(Sponsor)

実施施設 (1)

公立大学法人 奈良県立医科大学附属病院

Nara, Japan